Breaking News
Get 45% Off 0
⏰ Save Valuable Time with Faster Stock Data & Tools
Go Pro Now
Close

Heptagon Fund Icav - Driehaus Us Micro Cap Equity Fund C Usd Acc (0P00019XRB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
397.028 +6.000    +1.54%
30/01 - Closed. Currency in USD
  • Morningstar Rating:
  • Total Assets: 954.86M
Type:  Fund
Market:  Ireland
Issuer:  Heptagon Capital Limited
ISIN:  IE00BDB53K54 
Asset Class:  Equity
Heptagon Fund plc - Driehaus US Micro Cap Equity F 397.028 +6.000 +1.54%

0P00019XRB Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Heptagon Fund plc - Driehaus US Micro Cap Equity F (0P00019XRB) fund. Our Heptagon Fund plc - Driehaus US Micro Cap Equity F portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 0.540 0.540 0.000
Stocks 99.460 99.460 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 28.146 19.736
Price to Book 3.555 2.663
Price to Sales 2.691 1.841
Price to Cash Flow 6.452 11.272
Dividend Yield 0.167 0.946
5 Years Earnings Growth 19.206 11.939

Sector Allocation

Name  Net % Category Average
Healthcare 31.960 15.722
Industrials 18.570 21.361
Technology 13.740 19.862
Financial Services 12.510 12.586
Consumer Cyclical 9.900 12.044
Energy 4.660 4.781
Communication Services 3.920 2.945
Consumer Defensive 2.850 3.797
Basic Materials 1.600 4.479
Real Estate 0.280 3.955

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Africa & Middle East
  • Developed Markets

Top Holdings

Number of long holdings: 127

Number of short holdings: 0

Name ISIN Weight % Last Change %
  Crinetics Pharma US22663K1079 2.75 40.30 +0.10%
  Construction Partners US21044C1071 2.56 80.40 +0.47%
TeraWulf Inc - 2.16 - -
  Core Scientific US21874A1060 1.91 12.270 +0.08%
  Modine Manufacturing US6078281002 1.85 101.45 -0.99%
  Alkami Technology US01644J1088 1.74 34.79 -3.55%
  Rhythm Pharma US76243J1051 1.51 59.43 +0.35%
  Sterling Construction US8592411016 1.44 142.42 -2.92%
  OneSpaWorld BSP736841136 1.43 21.36 -1.11%
  FTAI Aviation KYG3730V1059 1.35 100.53 -2.73%

Top Equity Funds by Heptagon Capital Limited

  Name Rating Total Assets YTD% 3Y% 10Y%
  IE00BYZ09Q19 2.81B 32.32 4.98 -
  IE00BH4GYB17 1.24B 5.99 2.16 9.63
  IE00B61H9W66 409.92M 4.13 2.08 8.00
  IE00B94T1N53 409.92M 4.13 2.08 8.00
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00019XRB Comments

Write your thoughts about Heptagon Fund Icav - Driehaus Us Micro Cap Equity Fund C Usd Acc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email